Demand for Measurement and Analytical Instruments Driven by Pharmaceutical, Food Safety and Transportation-Related Projects

「The measuring instruments business worked to launch new products actively and strengthen its ability to propose solutions. It also strengthened after-sales services, including the multi-vendor service business, as well as reagents and consumables, and pursued expansion of its recurring business.」

「In the measuring instruments business, mass spectrometry systems and liquid chromatography systems increased in Japan, North America and other parts of Asia, driven by pharmaceutical R&D and quality control. In Europe, blood drug-concentration measurement and newborn screening systems increased in the healthcare field, while mass spectrometry systems for water-quality testing increased in the green field. In China, revenue declined as the private-sector market stagnated, but the company pursued active sales activities by capturing demand from government agencies and universities against the backdrop of government economic measures.」

「In the measuring instruments business, sales of liquid chromatographic analysis systems increased for research and development in the global pharmaceutical market within the healthcare sector and for quality control, mainly in Asia, while sales of mass spectrometry systems increased for the clinical market in the medtech sector. In addition, sales of testing machines increased for new materials development and other applications in the green/materials sector.」

「In the measuring instruments business, sales of liquid chromatographs for pharmaceuticals and clinical testing increased in the healthcare field. In the green field, sales of gas chromatographs increased for new-energy development, including hydrogen and ammonia. In addition, sales of testing equipment increased in the materials field for the development of new materials for hydrogen storage and lithium-ion batteries.」

「Under these circumstances, the Group was also affected by slower growth in its China business and persistently high raw material prices. However, across the 4 priority areas defined in its medium-term management plan—healthcare, green, materials and industry—the Group operated 4 businesses in measuring instruments, medical equipment, industrial equipment and aircraft equipment, working with partners around the world to address social issues.」

「Investment was strengthened in the healthcare field, centered on pharmaceuticals, where drug discovery research and domestic production are progressing globally, and in the green field, where initiatives addressing climate change are gaining momentum. Sales of priority products, including liquid chromatographs, mass spectrometry systems and gas chromatographs, increased. While making growth investments in human resources, R&D and capital expenditure, the company also worked to improve profitability by implementing price revisions.」

「The Measuring Instruments business achieved revenue growth both in Japan and overseas. Liquid chromatographs and mass spectrometry systems increased in the healthcare field, gas chromatographs increased in the green field, and testing machines increased in the materials field. The results of 島津ダイアグノスティクス株式会社, which became a consolidated subsidiary last September, also contributed.」

「Group net sales increased as sales of key products, including liquid chromatographs, mass spectrometry systems, and gas chromatographs, grew in the healthcare, green, and academic fields, supported by a recovery in production as the impact of parts and material shortages eased, as well as a rebound from the lockdowns caused by the spread of COVID-19 in China in the previous year.」

「The Measuring Instruments business was affected by the spread of the novel coronavirus in China and shortages of parts and materials. At the same time, global progress in drug discovery and the domestic production of pharmaceuticals increased demand for core liquid chromatographs in healthcare applications, particularly pharmaceuticals. In Japan, sales of novel coronavirus detection reagent kits increased as the number of infections rose, and the consolidation of 日水製薬株式会社 as a subsidiary also contributed to results.」

「In Japan, sales of gas chromatographs and testing machines increased for the green innovation sector targeting carbon neutrality.」

「In the measuring instruments business, liquid chromatographs for pharmaceuticals performed well as investment in the healthcare field expanded. Although the business was affected by supply constraints caused by shortages of semiconductor and other components and materials, as well as lockdowns in China, overseas revenue increased due to solid performance in Europe and other parts of Asia and the impact of foreign exchange. Domestic revenue declined due to lower sales of novel coronavirus detection reagent kits.」

「In healthcare, liquid chromatographs and mass spectrometry systems for pharmaceutical and contract analysis applications remained strong. Demand for testing associated with the spread of the novel coronavirus also increased sales of novel coronavirus detection reagent kits and fully automated PCR testing systems. In manufacturing, the business entered a recovery trend, with testing equipment for transportation equipment applications increasing. Among government agencies and universities, sales of liquid chromatographs, mass spectrometry systems, and other products increased as government budgets were executed in various countries and universities reopened.」

「In healthcare, core products such as liquid chromatographs and mass spectrometry systems performed well for pharmaceuticals and contract analysis. COVID-19 detection reagent kits and fully automated PCR testing systems contributed to results. In manufacturing, the recovery trend continued, with gas chromatograph sales increasing for chemical applications. Among government agencies and universities, sales of liquid chromatographs, mass spectrometry systems and other products increased as governments in various countries proceeded with budget execution and universities reopened.」

「In addition to strong performance by core liquid chromatographs and mass spectrometry systems for healthcare, government agencies and universities, sales of COVID-19 detection reagent kits and fully automated PCR testing systems also increased. In manufacturing, the recovery trend continues, with gas chromatograph sales increasing for chemical applications. Among government agencies and universities, sales of liquid chromatographs, mass spectrometry systems and other products increased as governments in various countries proceeded with budget execution and universities reopened.」

「In healthcare, liquid chromatographs and mass spectrometry systems, the main products for pharmaceuticals and contract analysis, performed well. Novel coronavirus detection reagent kits and fully automated PCR testing systems also contributed to results, mainly in Japan. In manufacturing, the business moved toward recovery as capital investment gradually increased. In the government and academic sectors, liquid chromatographs and other products increased as governments in various countries implemented their budgets and universities resumed research activities.」

「Novel coronavirus detection reagent kits and fully automated PCR testing systems for clinics contributed to measures against infectious diseases, while the healthcare fields, including pharmaceuticals and clinical applications, remained firm. The government and university sector began to recover in the second half, supported by economic measures implemented by governments in various countries.」

「The healthcare field, including pharmaceuticals and clinical applications, remained firm. Reagent kits for detecting COVID-19 and fully automated PCR testing systems for clinics launched in November 2020 contributed to infection-control measures. On the other hand, conditions remained challenging in industrial fields such as transport equipment and due to a decline in university-related projects.」

「The healthcare fields of pharmaceuticals, food and other areas remained firm, while COVID-19 detection reagent kits were widely used in Japan for infection diagnosis and contributed to performance. On the other hand, conditions remained challenging in industrial fields such as transport equipment and in the university market, which was affected by temporary campus closures.」

「The new COVID-19 detection reagent kit for PCR testing launched in April ramped up rapidly and contributed to performance, while environmental equipment also increased in Japan and overseas. However, due to the spread of COVID-19, liquid chromatographs, mass spectrometry systems that had grown substantially in the previous year's corresponding period, and testing machines mainly for the materials and automotive industries performed poorly.」

「Despite worsening business conditions, including the impact of US-China trade friction and the peaking of demand for environmental analysis equipment in China, first-half sales in this business remained strong, supported by the expanded product lineup following new product launches. Liquid chromatographs performed well for pharmaceutical and government customers, mass spectrometry systems for food safety and government customers, and testing equipment for the steel and transportation equipment industries. However, in the second half, the reaction to the consumption tax increase, an economic downturn in the transportation equipment industry, and, from the fourth quarter, the spread of the novel coronavirus led to restrained capital investment and postponed projects, resulting in a significant global impact.」

「In Japan, liquid chromatographs for government agencies, chemicals and food, mass spectrometry systems for government agencies and pharmaceutical companies, and testing machines for steel, automobiles and other transport equipment performed solidly. In North America, mass spectrometry systems used in hospitals declined, but testing machines and other products performed well, resulting in an overall increase. In Europe, mass spectrometry systems performed well in Russia for food-related applications, among others, resulting in a slight overall increase. In India, liquid chromatographs for pharmaceutical applications and mass spectrometry systems for contract analysis performed well. In China, mass spectrometry systems increased for universities, government agencies and contract analysis, but environmental measuring instruments declined sharply from the previous year's special demand, while gas chromatographs and spectrophotometers declined due to the reaction to large projects in the previous year and restrained capital investment. In Southeast Asia, liquid chromatographs for pharmaceutical applications performed well, but mass spectrometry systems for government agencies declined.」

「In North America, business remained strong in pharmaceuticals and food, although mass spectrometry systems used in hospitals declined. In China, mass spectrometry systems performed well for universities, government agencies and contract analysis, but environmental measuring instruments declined sharply following the reversal of the special demand seen in the previous year. Gas chromatographs and spectrophotometers also declined, owing in part to the reversal of large projects in the previous year and restrained capital expenditure.」

「In North America, gas chromatographs performed steadily in the petrochemical market. In Southeast Asia, liquid chromatographs and mass spectrometry systems performed well in the pharmaceutical and government and university markets, while in India they performed well in the contract analysis market. In Europe, however, sales declined due to stagnant market conditions and the impact of foreign exchange. In Japan, mass spectrometry systems for the pharmaceutical market and testing machines for the transportation equipment market grew and performed steadily, but overall revenue declined because there had been large projects for universities and other customers in the previous year. In China, liquid chromatographs for the pharmaceutical and contract analysis markets performed steadily and mass spectrometry systems performed well, but overall sales declined significantly because environmental measuring instruments fell sharply following the reaction to exceptional demand in the previous year.」

「In North America, liquid chromatographs and mass spectrometry systems performed well for healthcare applications. In Europe, liquid chromatographs and mass spectrometry systems performed well for universities and research institutions, food companies and contract analysis, among others. In China, environmental measuring instruments posted substantial sales growth as the government strengthened measures against sources of pollution, while gas chromatographs also performed well for contract analysis. In Southeast Asia, liquid chromatographs remained solid for pharmaceutical applications, and mass spectrometry systems for regulatory compliance also performed well. In India, sales declined as liquid chromatographs for pharmaceutical applications remained sluggish because of restrained capital expenditure on generic pharmaceuticals, among other factors.」

「In North America, liquid chromatographs and mass spectrometry systems performed well for healthcare applications. In Europe, liquid chromatographs and mass spectrometry systems performed well for universities and research institutions, as well as food and contract analysis applications. In China, environmental measuring instruments achieved substantial sales growth as the government strengthened measures to address pollution sources, while gas chromatographs also performed well for contract analysis. In Southeast Asia, liquid chromatographs performed steadily for pharmaceutical applications. In India, new gas chromatograph products performed well, although liquid chromatographs for pharmaceutical applications remained weak.」

「In North America, liquid chromatographs and mass spectrometry systems performed well in the healthcare, food and chemical markets. In Europe, mass spectrometry systems grew significantly in the university and research institution, food and contract analysis markets, while liquid chromatographs also performed well. In China, private-sector demand in areas such as chemicals and contract analysis and public-sector demand from universities were strong, resulting in solid performance centered on gas chromatographs and environmental measuring instruments. In Southeast Asia, nondestructive testing systems performed well in automotive-related markets, while in India, liquid chromatographs remained firm against a backdrop of recovery in the pharmaceutical market. In Japan, performance remained solid, with environmental measuring instruments growing in the energy market.」

「In North America, mass spectrometry instruments for clinical, chemical and government applications remained solid, but overall sales edged down due to delays in the progress of certain projects. In Europe, mass spectrometry instruments and liquid chromatographs for pharmaceutical and food applications remained solid. In China, the food safety, contract testing and environmental regulation sectors were active, and mass spectrometry instruments, liquid chromatographs, gas chromatographs and environmental measuring instruments performed well. In Japan, demand for liquid chromatographs for pharmaceutical and chemical applications and testing equipment for automobiles expanded, while government demand remained strong, particularly for gas chromatographs.」

「In North America, revenue declined, partly because some projects were delayed. In Europe, business remained strong, driven by liquid chromatographs and mass spectrometry systems for pharmaceuticals and food, supported by expansion in Western Europe and signs of recovery in Russia. In China, private-sector demand was buoyant across the board, including chemicals and electronics and electrical equipment, in addition to pharmaceuticals and contract analysis, and business remained strong, particularly in liquid chromatographs, gas chromatographs, mass spectrometry systems and environmental measuring instruments.」

「In China, liquid chromatographs and mass spectrometers performed well, driven by large projects involving food safety, the environment, and other areas, increased demand for regulatory compliance in the pharmaceutical field, and new demand related to clinical medicine in contract analysis. In Southeast Asia, liquid chromatographs performed well, while testing machines increased due to large projects for the transportation equipment sector. In India, liquid chromatographs and mass spectrometers for pharmaceutical applications continued to perform well.」

「In China, pharmaceutical and contract-testing markets drove private-sector demand, while large food-safety projects and other government-sector initiatives supported demand for liquid chromatographs and mass spectrometers. In Southeast Asia, liquid chromatographs remained firm, and testing machines increased on large transportation-equipment projects. In India, liquid chromatographs and mass spectrometers for pharmaceutical applications remained strong.」